Warning letter
Eminent Spine, LLC [ARCHIVED]: warning letter of Jul 20, 2010
FDA warning letter 124170 · Dallas District Office
Key facts
| Reference number | 124170 |
|---|---|
| Company | Eminent Spine, LLC [ARCHIVED] |
| Subject | CGMP/QSR/Medical Devices/Adulterated/Misbranded |
| Issue date | Jul 20, 2010 |
| Posted date | Jul 20, 2010 |
| Issuing office | Dallas District Office |
| Product type | Devices |
| CFR sections cited | 820, 820.40 |
| Inspection city | Plano |
| Inspection ZIP | 75093 |
| Inspection start date | Mar 1, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: